Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new windowYouTube page opens in new window
[email protected]+61 3 9692 7222
PharmAust (PAA)
Cancer Therapeutics Research
PharmAust (PAA)
  • HOME
  • ABOUT
    • Board
    • Management
    • Corporate Directory
  • PIPELINES & TRIALS
    • Monepantel for Motor Neurone Disease
    • Publications
  • INVESTOR HUB
    • ASX Announcements
    • Annual Reports
    • Investor Presentations
    • Analyst Reports
    • Financial Reports
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Videos
    • Media
  • CONTACT
  • HOME
  • ABOUT
    • Board
    • Management
    • Corporate Directory
  • PIPELINES & TRIALS
    • Monepantel for Motor Neurone Disease
    • Publications
  • INVESTOR HUB
    • ASX Announcements
    • Annual Reports
    • Investor Presentations
    • Analyst Reports
    • Financial Reports
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Videos
    • Media
  • CONTACT

Author Archives: PharmAust

GMP Tablet Production for Clinical Trials Commences

News & Announcements 2018By PharmAust13/11/2018

181113_GMP Tablet Manufacture_44070bgt7qng63

2018 AGM Results

News & Announcements 2018By PharmAust09/11/2018

2018 AGM Results

2018 AGM Presentation

News & Announcements 2018By PharmAust09/11/2018

2018 AGM Presentation

Top 20 Shareholders 31st October 2018

News & Announcements 2018, Top 20 ShareholdersBy PharmAust06/11/2018

Top_Holder_-_Detail_-_Single_Date October

Drug Reformulation Play With Significant Potential

News & Announcements 2018, Research Notes 2018By PharmAust06/11/2018

2018 11 05 PharmAust report from NDF Research This report has been commissioned and paid for by PharmAust (Company) and has been prepared by NDF Research, an Authorised Representative of BR Securities Australia Pty Ltd. The report solely reflects the views of Pitt Street Research. Any opinions, forecasts, recommendations or forward-looking statements in the report…

September 2018 Appendix 4C Quarterly Report and Company Update

Financial Reports 2018, News & Announcements 2018By PharmAust01/11/2018

43zxgv0spl3ht0

GMP Method for PharmAust Analogue Pipeline

News & Announcements 2018By PharmAust29/10/2018

181029_GMP_AAD_Manufacture

PharmAust Progresses Monepantel Tablet Program for Cancer

News & Announcements 2018By PharmAust14/10/2018

181015_Tablet_Update

Notice of Annual General Meeting: November 9

News & Announcements 2018By PharmAust10/10/2018

181010_Notice of Annual Meeting

October 8, Director’s Interest

News & Announcements 2018By PharmAust08/10/2018

181008_Director's Interest_

←1
23456789101112131415161718192021222324252627
…2829303132…
33343536373839404142434445464748495051
52→
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

PharmAust Follow

PharmAust is a clinical-stage biotech company focused on repurposing monepantel (MPL) for human neurodegenerative diseases ASX: $PAA FSE: $ECQ

PharmAust
pharmaust PharmAust @pharmaust ·
24 Jun 2024

📸 Highlights from the MND Australia Global Day Event at Parliament House!

We teamed up with FightMND to raise awareness and fight for a future free of Motor Neurone Disease. 💙

#MNDAustralia #FightMND #MNDGlobalDay

Reply on Twitter 1805134834358210569 Retweet on Twitter 1805134834358210569 2 Like on Twitter 1805134834358210569 12 Twitter 1805134834358210569
Retweet on Twitter PharmAust Retweeted
stockheadau Stockhead @stockheadau ·
21 Jun 2024

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.
#ASX @PharmAust

Reply on Twitter 1803984607676654065 Retweet on Twitter 1803984607676654065 1 Like on Twitter 1803984607676654065 3 Twitter 1803984607676654065
pharmaust PharmAust @pharmaust ·
21 Jun 2024

Exciting news for our investors! 🎉 Check out the details of our latest capital raise here: https://investorhub.pharmaust.com/investment-offer/32. Thank you for your continued support! 🌟 #PharmAust

Reply on Twitter 1804030728956711230 Retweet on Twitter 1804030728956711230 2 Like on Twitter 1804030728956711230 7 Twitter 1804030728956711230
Load More

Copyright © 2025 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top